We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+3.89%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$5.36B
AUM Growth
-$370M
Cap. Flow
-$116M
Cap. Flow %
-2.16%
Top 10 Hldgs %
30.29%
Holding
272
New
25
Increased
53
Reduced
155
Closed
28

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$46.5M
2
ENPH icon
Enphase Energy
ENPH
+$38.5M
3
TSLA icon
Tesla
TSLA
+$35M
4
LFG
Archaea Energy Inc.
LFG
+$29.8M
5
CALX icon
Calix
CALX
+$29.5M

Sector Composition

Rank Sector Weight
1 Technology 33.08%
2 Healthcare 19.9%
3 Consumer Discretionary 17.94%
4 Industrials 9.82%
5 Communication Services 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHAT icon
126
Phathom Pharmaceuticals
PHAT
$678M
$6.19M 0.12%
551,827
-615
-0.1% -$6.34K
DDOG icon
127
Datadog
DDOG
$81.3B
$5.93M 0.11%
80,621
-64,797
-45% -$5.06M
APA icon
128
APA Corp
APA
$16.4B
$5.37M 0.1%
115,111
-25,759
-18% -$1.15M
CNR
129
Core Natural Resources Inc
CNR
$4.69B
$5.34M 0.1%
82,154
-166
-0.2% -$11.2K
VZ icon
130
Verizon
VZ
$214B
$5.32M 0.1%
135,039
-2,000
-1% -$75.4K
ETSY icon
131
Etsy
ETSY
$6.78B
$5.19M 0.1%
43,304
-4,013
-8% -$459K
PAG icon
132
Penske Automotive Group
PAG
$14.2B
$5.18M 0.1%
45,100
SPNT icon
133
SiriusPoint
SPNT
$2.84B
$5.03M 0.09%
851,759
-4,442
-0.5% -$26.1K
RCUS icon
134
Arcus Biosciences
RCUS
$2.99B
$4.94M 0.09%
238,839
-2,388
-1% -$65.7K
AGI icon
135
Alamos Gold
AGI
$14.6B
$4.89M 0.09%
483,609
+89
+0% +$783
SNAP icon
136
Snap
SNAP
$9.96B
$4.73M 0.09%
528,686
-772,106
-59% -$7.62M
TSCO icon
137
Tractor Supply
TSCO
$17.1B
$4.73M 0.09%
105,045
+10,700
+11% +$454K
PTON icon
138
Peloton Interactive
PTON
$2.11B
$4.67M 0.09%
587,822
-357,393
-38% -$3.43M
VMC icon
139
Vulcan Materials
VMC
$32.2B
$4.56M 0.09%
26,038
-326
-1% -$55.7K
RNR icon
140
RenaissanceRe
RNR
$13.7B
$4.48M 0.08%
+24,317
New +$4.1M
SKE
141
Skeena Resources
SKE
$3.83B
$4.43M 0.08%
833,447
-58,267
-7% -$296K
ELF icon
142
e.l.f. Beauty
ELF
$5.73B
$4.41M 0.08%
79,740
+15,144
+23% +$742K
COST icon
143
Costco
COST
$403B
$4.35M 0.08%
9,536
-927
-9% -$453K
CDXS icon
144
Codexis
CDXS
$159M
$4.31M 0.08%
925,828
-534,085
-37% -$2.93M
BEAM icon
145
Beam Therapeutics
BEAM
$2.4B
$4.23M 0.08%
108,116
-11,105
-9% -$497K
NARI
146
DELISTED
Inari Medical, Inc. Common Stock
NARI
$4.22M 0.08%
66,404
-25,750
-28% -$1.87M
PLNT icon
147
Planet Fitness
PLNT
$3.75B
$3.99M 0.07%
50,671
-4,992
-9% -$348K
FERG icon
148
Ferguson
FERG
$42B
$3.77M 0.07%
29,687
-109
-0.4% -$12.7K
APEN
149
DELISTED
Apollo Endosurgery, Inc.
APEN
$3.72M 0.07%
373,005
-88,582
-19% -$661K
ARGX icon
150
argenx
ARGX
$61.9B
$3.69M 0.07%
9,748
-17
-0.2% -$6.36K

Similar funds

Gilder Gagnon Howe & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Gilder Gagnon Howe & Co held 272 positions worth $5.36B, down 6.5% from $5.73B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Gilder Gagnon Howe & Co's Q4 2022 filing shows 25 new, 53 increased, 155 reduced and 28 closed positions. Its largest new stake was Chart Industries: 284,553 shares worth $32.8M. The largest sale was Novo Nordisk, an estimated $46.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Gilder Gagnon Howe & Co's largest Q4 2022 buy was Chart Industries: 284,553 shares worth $32.8M.
  • Gilder Gagnon Howe & Co added most to Canadian Pacific Kansas City in Q4 2022, an estimated $80.1M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $46.5M.
  • Gilder Gagnon Howe & Co fully exited Archaea Energy Inc. in Q4 2022, selling an estimated $29.8M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 30% of its $5.36B portfolio in Q4 2022.
  • Gilder Gagnon Howe & Co opened 25 new positions and closed 28 in Q4 2022.
  • Gilder Gagnon Howe & Co's portfolio value fell 6.5% quarter-over-quarter to $5.36B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2022, filed 14 Feb 2023.